STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $400,000 | -66.5% | 196,365 | -51.2% | 0.00% | – |
Q2 2021 | $1,195,000 | +930.2% | 402,297 | +857.9% | 0.00% | – |
Q1 2021 | $116,000 | +107.1% | 41,998 | +82.4% | 0.00% | – |
Q4 2020 | $56,000 | -17.6% | 23,023 | -28.7% | 0.00% | – |
Q3 2020 | $68,000 | -43.8% | 32,303 | +0.9% | 0.00% | – |
Q2 2020 | $121,000 | +157.4% | 32,009 | +29.2% | 0.00% | – |
Q1 2020 | $47,000 | -33.8% | 24,766 | -27.7% | 0.00% | – |
Q4 2019 | $71,000 | +1.4% | 34,240 | +16.4% | 0.00% | – |
Q3 2019 | $70,000 | -20.5% | 29,426 | +4.9% | 0.00% | – |
Q2 2019 | $88,000 | -81.7% | 28,039 | -70.9% | 0.00% | – |
Q1 2019 | $480,000 | +451.7% | 96,342 | +398.2% | 0.00% | – |
Q4 2018 | $87,000 | -85.3% | 19,338 | -84.1% | 0.00% | – |
Q3 2018 | $590,000 | -74.7% | 121,587 | -68.7% | 0.00% | -100.0% |
Q2 2018 | $2,330,000 | +756.6% | 388,395 | +1163.0% | 0.00% | – |
Q1 2018 | $272,000 | 0.0% | 30,752 | -18.1% | 0.00% | – |
Q4 2017 | $272,000 | – | 37,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |